Caris Life Sciences, Inc. (CAI)

30.63 -0.92 (-2.92%) USD  |  NASDAQ  |  Sep 30, 16:00
30.60 -0.03 (-0.10%) After-Hours: 07:23
More

Caris Life Sciences Cash and Short Term Investments (Quarterly) : 793.12M for June 30, 2026

Cash and Short Term Investments (Quarterly) Chart

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2024. Start Trial.
Date Value
June 30, 2026 793.12M
March 31, 2026 823.46M
December 31, 2025 800.09M
September 30, 2025 757.01M
Date Value
June 30, 2025 722.69M
March 31, 2025 34.93M
December 31, 2024 67.64M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
CareDx, Inc. 373.64M
Natera, Inc. 1.092B
Myriad Genetics, Inc. 115.20M
BioRestorative Therapies, Inc. 3.592M
Exagen, Inc. 24.59M